The vast majority of patients who initiated imatinib therapy for gastrointestinal stromal tumors (GISTs) received a generic drug that did not have FDA approval for that indication, a large ...
A new court ruling has the future use of skinny labels in question, but skinny-label generics have saved Medicare a lot of money over 5 years. Skinny labels, which carve out patent-protected ...
Current Federal Drug Administration regulations require a generic drug’s labeling to be the same as its brand-name counterpart. Brand-name drug manufacturers are able to update product labels with new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback